IPO IPO-Synopsis
Asston Pharmaceuticals Ltd

Back

Registered Office: 4th Flr Office No.A-431 Balaji,Bhavan Plot No.42A Sec-11 CBD , Mumbai - 400614 , Maharashtra , India.
Phone : +91 22 4973 1411/+91 22 4973 1419   Fax:
Email :  info@asstonpharmaceuticals.com  
Website :  www.asstonpharmaceuticals.com
Initial public issue of up to 22,41,000 equity shares of face value of Rs10/- each (the "Equity Shares") of Asston Pharmaceuticals Limited ("the Company" or "APL" or "the Issuer") at an issue price of Rs123 per equity share for cash, aggregating up to Rs27.56 crores ("Public Isue") out of which upto 1,13,000 equity shares of face value of Rs10/- each, at an issue price of Rs123 per equity share for cash, aggregating Rs1.39 crores will be reserved for subscription by the market maker to the issue (the "Market Maker Reservation Portion"). The public issue less market maker reservation portion i.e. issue of upto 21,28,000 equity shares of face value of Rs10/- each, at an issue price of Rs123 per equity share for cash, aggregating upto Rs26.17 crores is herein after referred to as the "Net Issue". The public issue and net issue will constitute 26.33 % and 25 %, respectively of the post-issue paid-up equity share capital of the company.

Issue Money Payable On
Opens On Closes On Application Allotment
09-Jul-25 11-Jul-25 Rs123.00-0.00 Rs0.00-0.00
Minimum Application for shares in Nos :2000  Further Multiples of :1000

  Rs Cr Lead Managers to the Issue
Project Cost 23.95
Sobhagya Capital Options Pvt. Ltd.
Project Financed through Current Offer 27.56  
Post Issue Equity Share Capital 8.51  
Issue Price Rs123.00  
Projects
Funding capital expenditure requirements towards acquiring machinery in the manufacturing unitRepayment and/or prepayment, in part or full, of certain of our outstanding borrowings availed by our company.
Funding the incremental working capital requirements of our companyGeneral corporate purposes
Promoted By
Ashish Narayan Sakalkar
Saili Jayaram More
Sachin Chandrakant Badakh
Listing At
BSE - SME 
Registrar to the Issue
Maashitla Securities Pvt Ltd